Home
World Journal of Advanced Research and Reviews
International Journal with High Impact Factor for fast publication of Research and Review articles

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

eISSN: 2581-9615 || CODEN: WJARAI || Impact Factor 8.2 ||  CrossRef DOI

Research and review articles are invited for publication in April 2026 (Volume 30, Issue 1) Submit manuscript

A prospective study on efficacy of nicorandil and isosorbide mononitrate in coronary artery disease

Breadcrumb

  • Home
  • A prospective study on efficacy of nicorandil and isosorbide mononitrate in coronary artery disease

Kishore Bandarapalle 1, *, Narasapuram Sravani 2, Manige Hari Deepika 2, Vaddi Snehalatha 2, Gunthanakkala Soumya 2, Eduga Thulasi 2 and Kanta Chandu Priya 2

1 Department of Pharmaceutics, Sri Padmavathi School of Pharmacy, Tiruchanoor, Tirupati, Chittoor, Andhra Pradesh 517503, India.
2 Doctor of Pharmacy, Sri Padmavathi School of Pharmacy, Tiruchanoor, Tirupati, Chittoor, Andhra Pradesh 517503, India.
 
Research Article
World Journal of Advanced Research and Reviews, 2024, 21(01), 2388-2398
Article DOI: 10.30574/wjarr.2024.21.1.0243
DOI url: https://doi.org/10.30574/wjarr.2024.21.1.0243
 
Received on 10December 2023; revised on 17 January 2024; accepted on 20 January 2024
 
Background: The aim of this prospective study was to assess the efficacy of Nicorandil (NR) and Isosorbide Mononitrate (ISMN) in coronary artery disease (CAD). Nicorandil strengthens CAD treatment by inhibiting cardiac fatty acid oxidation, easing aggravation and improving heart function, which is critical for preventing heart failure and other significant consequences.
Methods: 110 patients with CAD were selected as research subjects and randomly assigned to two groups: observational (Group O) and control (Group C), with 55 patients in each. The control group was given traditional CAD treatment, whereas the observational group received NR and ISMN in addition to conventional treatment. The blood pressure, CRP, left ventricular ejection fraction (LVEF), troponin T, and ST-segment levels of two groups were assessed and compared at baseline, as well as after the second and fourth months, respectively.
Results: This study found significant differences (P<0.05) between the observational and control groups in terms of BP, CRP, troponin T, and ST segment levels after the second and fourth months, whereas LVEF rose significantly (P<0.05) using one-way ANOVA. Similarly, an independent t-test was used to assess significant improvements in each group.
Conclusions: The addition of Nicorandil and Isosorbide Mononitrate to a standard CAD regimen was found to have an important association with LVEF and inflammatory mediators, which can significantly improve cardiac functions while also preventing other cardiovascular complications in patients with coronary artery disease.
 
Nicorandil; Isosorbide Mononitrate; Coronary Artery Disease
 
https://wjarr.com/sites/default/files/fulltext_pdf/WJARR-2024-0243.pdf

Preview Article PDF

Kishore Bandarapalle, Narasapuram Sravani, Manige Hari Deepika, Vaddi Snehalatha, Gunthanakkala Soumya, Eduga Thulasi and Kanta Chandu Priya. A prospective study on efficacy of nicorandil and isosorbide mononitrate in coronary artery disease. World Journal of Advanced Research and Reviews, 2024, 21(1), 2388-2398. Article DOI: https://doi.org/10.30574/wjarr.2024.21.1.0243

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 World Journal of Advanced Research and Reviews - All rights reserved

Developed & Designed by VS Infosolution